CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs.
Industries 3D Printing3D TechnologyBiotechnologyHealth CareMedicalMedical DeviceWellnessHeadquarters Regions Europe, Middle East, and Africa (EMEA), Middle East Sub-Organization of Yissum Technology Transfer Company of the Hebrew UniversityFounded Date 1981 Operating Status Active Last Funding Type Post-IPO Equity Legal Name CollPlant Ltd
Stock Symbol NASDAQ:CLGN Company Type For Profit
Contact Email info@collplant.com Phone Number +972 73 2325600
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is
ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds.
CollPlant is headquartered in Rehovot, Israel.